Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Ciclosporin/Mycophenolate-mofetil

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cros G, et al. A novel variant in caspase recruitment domain family member 11 highlights the variability of clinical manifestations and management in a three generation family. Journal of Allergy and Clinical Immunology: In Practice 11 : 3265-3268, No. 10, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.jaip.2023.06.041 Cros G, et al. A novel variant in caspase recruitment domain family member 11 highlights the variability of clinical manifestations and management in a three generation family. Journal of Allergy and Clinical Immunology: In Practice 11 : 3265-3268, No. 10, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​jaip.​2023.​06.​041
Metadaten
Titel
Ciclosporin/Mycophenolate-mofetil
Lack of efficacy
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58082-7

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Paclitaxel

Case report

Multiple drugs

Case report

Phenytoin